Show items per page
Elements: 35
Page 1 on 2
 TitleAuthors / EditorsDate
add to browser selection
Antivirale Substanzen: Gegen was? Fur wen? Hirschel, Bernard 1990
add to browser selection
Combination therapy in primary HIV infection Perrin, Luc; Hirschel, Bernard 1996
add to browser selection
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study Egger, M.; Hirschel, Bernard; Francioli, Patrick; Sudre, Philippe; ... Battegay, M. 1997
add to browser selection
Adding saquinavir to stavudine in patients with advanced HIV-1 infection Rutschmann, Olivier Thierry; Kaiser, Laurent; Perrin, Luc; Fathi, Marc; Hirschel, Bernard 1997
add to browser selection
A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study Rutschmann, Olivier Thierry; Opravil, M.; Iten, A.; Malinverni, R.; ... Hirschel, Bernard 1998
add to browser selection
Progress and problems in the fight against AIDS Hirschel, Bernard; Francioli, P. 1998
add to browser selection
Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study Rutschmann, Olivier Thierry; Opravil, M.; Iten, A.; Malinverni, R.; ... Hirschel, Bernard 1998
add to browser selection
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study Furrer, Hansjakob; Egger, M.; Opravil, M.; Bernasconi, Enos; ... Malinverni, R. 1999
add to browser selection
Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study Zinkernagel, C.; Ledergerber, Bruno; Battegay, M.; Cone, R. W.; ... Opravil, M. 1999
add to browser selection
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study Rutschmann, Olivier Thierry; Vernazza, P. L.; Bucher, H. C.; Opravil, M.; ... Hirschel, Bernard 2000
add to browser selection
Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study Group Joly, V.; Moroni, M.; Concia, Ercole; Lazzarin, A.; ... de Cian, W. 2000
add to browser selection
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study Friedl, A. C.; Ledergerber, Bruno; Flepp, Markus; Hirschel, Bernard; ... Weber, R. 2001
add to browser selection
Modern anti-HIV therapy Flepp, Markus; Schiffer, V.; Weber, R.; Hirschel, Bernard 2001
add to browser selection
Antiretroviral prophylaxis for community exposure to the human immunodeficiency virus in Switzerland, 1997-2000 Bernasconi, Enos; Jost, J.; Ledergerber, Bruno; Hirschel, Bernard; ... Sudre, Philippe 2001
add to browser selection
Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients Battegay, M.; Vernazza, P. L.; Bernasconi, Enos; Flepp, Markus; ... Hirschel, Bernard 2001
add to browser selection
Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study Bernasconi, Enos; Boubaker, Karim; Junghans, Cornelia; Flepp, Markus; ... Telenti, Amalio 2002
add to browser selection
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study Bucher, H. C.; Bichsel, M.; Taffe, Patrick; Furrer, Hansjakob; ... Battegay, M. 2002
add to browser selection
Beware of drug holidays before HIV salvage therapy Hirschel, Bernard 2003
add to browser selection
Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection Hirsch, M. S.; Steigbigel, R. T.; Staszewski, Scholomo; McMahon, Deborah; ... Leavitt, R. Y. 2003
add to browser selection
Saquinavir trough concentration before and after switching NRTI to tenofovir in patients treated with once-daily saquinavir hard gel capsule/ritonavir 1600 mg/100 mg Ananworanich, Jintanat; Siangphoe, Umaporn; Mahanontharit, Apicha; Hill, Andrew; ... Ruxrungtham, Kiat 2004
<< previous | 1 | 2 |